USPTO serial 86794366
TRANSFORMATIVE PHARMACEUTICAL SOLUTIONS
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Nov 27, 2018
- Examiner
- MURRAY, GEORGE WILLIAM
- Law office
- Historical data usage
What this means
Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use. Continue use in commerce and plan for the 10-year Section 8 and 9 renewal.
Need help with TRANSFORMATIVE PHARMACEUTICAL SOLUTIONS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Transformative Pharmaceutical Solutions, LLC
Blue Bell, PA
Other trademarks owned by Transformative Pharmaceutical Solutions, LLC
Transformative Pharmaceutical Solutions, LLC
Blue Bell, PA
Other trademarks owned by Transformative Pharmaceutical Solutions, LLC
Transformative Pharmaceutical Solutions, LLC
Blue Bell, PA
Other trademarks owned by Transformative Pharmaceutical Solutions, LLC
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Susan A. Smith
Susan A. Smith Ballard Spahr LLP1909 K Street, NW12th FloorWashington, DC 20006-1157Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 035 | clinical research site management and monitoring, namely, identifying, qualifying, and selecting sites for clinical trials, negotiating clinical trial site contracts and budgets, organizing and conducting business meetings of clinical trial investigators, assisting investigators with developing business strategies for recruiting clinical trial participants, submitting clinical trial protocols to institutional review boards and independent ethics committees, monitoring clinical trial investigators' activities for compliance with clinical protocols and regulations and for patient safety; employment staffing in the field of clinical trials; business information management; business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, pharmaceutical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval; business project management in the field of clinical trials; providing the services of vendor management to medical, pharmaceutical, biopharmaceutical and biotechnology companies, namely, selecting and managing third-party providers of services that support clinical trials | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Transformative Pharmaceutical Solutions, LLC
- Other trademarks owned by Transformative Pharmaceutical Solutions, LLC
- Other trademarks owned by Transformative Pharmaceutical Solutions, LLC
- Other trademarks in Class 035
- Similar marks named TRANSFORMATIVE PHARMACEUTICAL SOLUTIONS
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 16, 2024 | NA85 | NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED | — |
| Oct 16, 2024 | C15A | REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. | — |
| Oct 16, 2024 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Apr 17, 2024 | E815 | TEAS SECTION 8 & 15 RECEIVED | — |
| Nov 27, 2023 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Sep 27, 2022 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Sep 27, 2022 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Sep 27, 2022 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 27, 2022 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Sep 27, 2022 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Nov 27, 2018 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Oct 26, 2018 | SUNA | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | — |
| Oct 25, 2018 | CNPR | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | — |
| Oct 25, 2018 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| Oct 25, 2018 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Oct 1, 2018 | IUAF | USE AMENDMENT FILED | — |
| Oct 1, 2018 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| Mar 15, 2018 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Mar 13, 2018 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Mar 13, 2018 | EXT1 | SOU EXTENSION 1 FILED | — |
| Mar 13, 2018 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Nov 28, 2017 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Oct 18, 2017 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Oct 18, 2017 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Oct 3, 2017 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Oct 3, 2017 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Sep 13, 2017 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Aug 28, 2017 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Aug 22, 2017 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| Feb 16, 2017 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Feb 16, 2017 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Feb 16, 2017 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Feb 8, 2017 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 8, 2017 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 8, 2017 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| Dec 16, 2016 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| Jun 16, 2016 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Jun 16, 2016 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Jun 16, 2016 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Jun 9, 2016 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 9, 2016 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 2, 2016 | ALIE | ASSIGNED TO LIE | — |
| May 20, 2016 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 19, 2016 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 19, 2016 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 19, 2016 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 11, 2016 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 26, 2015 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Oct 24, 2015 | NWAP | NEW APPLICATION ENTERED | — |